InsidersTradesSigma
Follow the タカラバイオ株式会社 stock price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares are listed on JP JP, under the oversight of EDINET (Japan FSA). The latest transaction was filed on 21 April 2026 (Holding update). Among the most active insiders: Nomura Asset Management Co., Ltd.. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Takara Bio Inc. is a Japanese biotechnology company that provides products and services in research and development. It is listed on the Tokyo Stock Exchange under the symbol XTKS.